Practical checklist of changes to comply with new Medical Device Regulation (MDR) requirements now available
June 2017 - Agreement has at last been reached on the new European Medical Device Regulation (MDR), which officially came into effect in May 2017. The new regulation has consolidated two existing legal provisions and replaced both the current Medical Device Directive (93/42/EEC) and the Active Implantable Medical Device Directive (90/385/EEC). The new MDR will inevitably bring about important changes within the industry so it is imperative that manufacturers understand the full impact of the MDR on their business and do not delay formulating a strategy to ensure compliance.
In order to help manufacturers understand the imminent changes and their impact, Maetrics, a leading international consulting firm focusing on providing life science companies with deep quality, compliance and regulatory solutions, has published a free whitepaper that is available to download here: New Medical Device Regulation Requirements
Peter Rose, Managing Director, Europe at Maetrics, explains “the new regulation is going to bring about an unprecedented change to the European regulatory environment for medical devices. This must-read guide comprehensively lists the changes to the regulatory framework and highlights a preferable course of action for manufacturers to take in order to sufficiently prepare for MDR.”
The guide particularly focuses on:
• Significant changes in the MDR and their implication for manufacturers, including: reclassification, market access of legacy products, reprocessing of single use devices, technical documentation, clinical evaluation, vigilance and post market surveillance, mandatory product liability insurance, transparency, supply chain, labeling, and UDI;
• Practicalities of implementation, looking closely at: Brexit, Notified Body capacity and numbers, Delegating Acts and the ISO 13485 Quality System;
• Suggested next steps, which include suggested steps to achieving compliance.
Jens Weirsoe, Director Solutions Delivery at Maetrics in DACH, comments: “The New Medical Device Regulation is a complex document and the changes it embodies are significant. The new regulation comes with a three year transition period following its publication and is expected to come into full effect in 2020, after this date it will no longer be possible to put a new medical device on the market with a CE mark issued against the former Directive 93/42/EEC so it is vital that businesses sit up and take notice now.”
Mike Wolf, Director Solutions Delivery at Maetrics in North America, adds: “this new whitepaper is extremely easy to read and should be used by manufacturers as a practical tool in order to not shirk on compliance. The whitepaper provides an easy to follow checklist for manufacturers to ensure a pragmatic approach is taken to achieve MDR compliance. Since this new European Medical Device Regulation came into effect, one thing is clear – manufacturers must begin preparing for the changes as a matter of urgency.”
--- end ---
Founded in 1984, Maetrics is a global life sciences consulting firm focused exclusively on regulatory, quality, and compliance solutions for Medical Device, Diagnostic, Pharmaceutical and Biotechnology companies. With offices throughout Europe and North America, Maetrics can assist with local, regional, or global compliance needs.
7–9 Praed Street
London W2 1NJ
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Practical checklist of changes to comply with new Medical Device Regulation (MDR) requirements now available here
News-ID: 570118 • Views: 169
More Releases from Maetrics
Maetrics appoints Elizma Parry to lead Clinical Practice
January 2019 – Maetrics, a global leader in life sciences consulting, has appointed Elizma Parry to Director of the Global Clinical Practice. A highly qualified industry professional, Elizma is a proven leader with a strong track record of clinical safety, regulatory and quality management experience. She is leading the company’s clinical practice which is dedicated to delivering effective clinical and performance evidence for international medical device and IVD regulatory compliance.
Maetrics Shine a Spotlight on Clinical Evaluation Reports in the Medical Device …
New Maetrics whitepaper highlights the compliance changes to CERs in light of the new EU Medical Device Regulations and how to navigate them September 2018 – Maetrics, a leading international life sciences regulatory and compliance consultancy, have launched a new report providing clarity to medical device manufacturers on the requirements for properly documented, up-to-date Clinical Evaluation Reports (CER). Correctly implementing the requirements for clinical evaluation is paramount for any manufacturer wishing
Maetrics at Medica 2017: Stand F18-5, Hall 16
Global life sciences consultancy to present original research whitepaper on importance of speedy MDR compliance at Medica 2017 Nottingham, 06 November 2017 – Maetrics, the global consultancy firm that provides regulatory, quality, and compliance solutions to the life sciences sector, today announces its attendance at this month’s Medica trade fair in Düsseldorf (13-16 November 2017). The company will exhibit on Stand F18-5, Hall 16 and will have senior executives available
Maetrics appoints Brian Moan to European Solutions Delivery Team
15 September 2017 – Maetrics, a global leader in life science consulting, has appointed Brian Moan to Director of Solutions Delivery in Europe. A highly qualified industry expert, Brian is a proven leader with a strong track record in regulatory compliance as well as product quality and design. With over 20 years of experience working with medical device manufacturers, Brian brings extensive industry experience to Maetrics and is ready
More Releases for MDR
Lawsuit filed for Investors in shares of McDermott International, Inc. (NYSE: MD …
An investor, who purchased shares of McDermott International, Inc. (NYSE: MDR) (OTC: MDRIQ), filed a lawsuit over alleged violations of Federal Securities Laws by McDermott International, Inc. Investors, who purchased a significant amount of shares of McDermott International, Inc. (NYSE: MDR) (OTC: MDRIQ) between September 20, 2019 and January 23, 2020, have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2020. NYSE: MDR, OTC:
SGS Keeps Manufacturers Up-to-Date with Europe’s New Medical Device Regulation …
The European Union’s new Medical Device Regulation (MDR) 2017/745 came into force on May 26, 2017, superseding Medical Device Directive (MDD) 93/42/EC. This began a three-year transition period, meaning all new devices, their manufacturers and other stakeholders in the field must meet the requirements of the MDR by May 26, 2020. During the transition period Notified Bodies (NB) may grant device certification according to the MDD. The certificates are valid for
Managed Detection and Response (MDR) Market: Industry Size, Share, Growth, Forec …
MarketResearchReports.Biz announces addition of new report "Managed Detection and Response (MDR) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its database. The objectives of this study are as follows: To define, describe, and forecast the "Managed Detection and Response (MDR)" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific
Paladion Announces Fully Integrated AI-Driven MDR at Gartner Security & Risk Man …
Paladion, a global leader in cyber defense solutions, today announced fully integrated AI-Driven Managed Detection and Response Services at Gartner Security & Risk Management Summit 2018. Targeted artificial intelligence (AI) from Paladion now supports security experts for faster, more accurate, more effective threat anticipation, security analytics, and response actions. The new-generation high-speed cyber defense powered by Paladion’s AI.saac platform lets human security experts defend against the increasing volume and diversity
Indian Retail Industry Poised for Big Growth Post MDR Withdrawal
Chennai, December 27, 2017: Come January 2018, retailers can rejoice as they don’t need to pay Merchant Discount Rate (MDR) charges to banks for every debit card payment they receive. The government’s recent decision to abolish MDR for small and medium retail merchants over the digital transactions through debit card up to Rs 2000 has come as a welcome relief for thousands of retail businesses across the country as they were
Managed Detection and Response (MDR) Market Investment Research Report 2025
Managed detection and response (MDR) improves incident response capabilities and threat detection monitoring through a turnkey approach which detects threats that have evaded other controls. Risk and security management providers are understanding the importance of MDR services and its impact for their environments. New service providers have developed solutions to support businesses seeking to increase their incident response and threat detection capabilities. Additionally, MDR vendors deliver services for purchasers looking